Close

VOLUNTARY ANNOUNCEMENT - RISVUTATUG REZETECAN FOR INJECTION (HS-20093) FOR OSTEOSARCOMA INCLUDED IN PRIORITY REVIEW AND APPROVAL PROCEDURE OF THE NMPA

Attachments

HKEX-EPS_20260922_12341168_0.PDF